Advertisement
Journal Home
Search for

Articles in Press

Return to articles in press list

Novel cationic fullerenes as broad-spectrum light-activated antimicrobials

Liyi Huangabc, Mitsuhiro Terakawaad, Timur Zhiyentayevae, Ying-Ying Huangabf, Yohei Sawayamaag, Ashlee Jahnkeh, George P. Tegosab, Tim Whartonh, Michael R. HamblinabiCorresponding Author Informationemail address

Received 4 August 2009; received in revised form 8 October 2009; accepted 23 October 2009. published online 16 November 2009.
Accepted Manuscript

Abstract 

Photodynamic inactivation (PDI) is a rapidly developing antimicrobial technology which combines a non-toxic photoactivatable dye or photosensitizer (PS) in combination with harmless visible light of the correct wavelength to excite the dye to its reactive triplet state that will then generate reactive oxygen species (ROS) that are highly toxic to cells. Buckminsterfullerenes are closed-cage molecules entirely composed of sp2 hybridized carbon atoms and although their main absorption is in the UV, they also absorb visible light and have a long-lived triplet state. When C60 fullerene is derivatized with cationic functional groups it forms molecules that are more water-soluble and can mediate PDT efficiently upon illumination, and moreover cationic fullerenes can selectively bind to microbial cells. In this report we describe the synthesis and characterization of several new cationic fullerenes. Their relative effectiveness as broad-spectrum antimicrobial photosensitizers against Gram-positive, Gram-negative bacteria, and a fungal yeast was determined by quantitative structure function relationships.

No full text is available. To read the body of this article, please view the PDF online.

a Wellman Center for Photomedicine, Massachusetts General Hospital, Boston, MA

b Department of Dermatology, Harvard Medical School, Boston, MA

c Department of Infectious Diseases, First Affiliated College & Hospital, Guangxi Medical University, Nanning, China

d Department of Electronics and Electrical Engineering, Keio University, Japan

e Chemistry Department, Massachusetts Institute of Technology, Cambridge, MA

f Aesthetic and Plastic Center, Guangxi Medical University, Nanning, China

g Graduate School of Engineering, University of Tokyo, Japan

h Lynntech Inc, College Station, TX

i Harvard-MIT Division of Health Sciences and Technology, Cambridge, MA

Corresponding Author InformationCorresponding author. 40 Blossom Street, BAR414, Wellman Center for Photomedicine, Massachusetts General Hospital, Boston, MA 02114-2696. Tel.: +617 726 6182; fax: +617 726 6182.

PII: S1549-9634(09)00253-6

doi:10.1016/j.nano.2009.10.005

Advertisement